The group's principal activities are to discover and develop new drugs to treat a range of inflammatory and neurological disorders. The products of the group are used to treat a range of neurological disorders such as traumatic brain injury, stroke, neuropathic pain. Lotemax is a steroid used to treat steroid responsive inflammatory eye conditions and also used for cataract surgery. Alrex is used in the treatment of ophthalmic allergies. The group's products include loteprednol etabonate and dexanabinol, which are used for traumatic brain injury and tamoxifen analogs. The group's operations are conducted in the United States and Israel. The Israel, operations are conducted through its subsidiary, pharmos ltd.
